Explora BioLabs’ CEO, Richard Lin, will be attending the Redefining Early Stage Investments (RESI) Conference in Boston on September 13, 2016. This conference is the 10th in an ongoing conference series that has a stated goal of “establishing a global circuit for early stage life sciences companies to source investors, create relationships, and eventually, get funding.”
At the conference, Richard will be meeting potential strategic partners to discuss Explora’s South San Francisco expansion plans for early 2017, as well as its current preclinical research and vivarium operations in San Diego.
Past RESI conferences have been proven opportunities for Explora to evaluate the latest trends in emerging biotechnology investment and research. More information about the RESI conference can be found here.